We are live on ! Find out more
DERM

Dermira, Inc.
DERM

Delisted

DERM was delisted on the 19th of February, 2020.

134 hedge funds and large institutions have $1.19B invested in Dermira, Inc. in 2017 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 50 increasing their positions, 36 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

942% more call options, than puts

Call options by funds: $2.26M | Put options by funds: $217K

124% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 17

39% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 36

33% more capital invested

Capital invested by funds: $890M → $1.19B (+$297M)

14% more funds holding

Funds holding: 118134 (+16)

17% less funds holding in top 10

Funds holding in top 10: 65 (-1)

Holders
134
Holders Change
+16
Holders Change %
+13.56%
% of All Funds
3.33%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.12%
New
38
Increased
50
Reduced
36
Closed
17
Calls
$2.26M
Puts
$217K
Net Calls
+$2.04M
Net Calls Change
+$1.03M
Name Holding Trade Value Shares
Change
Change in
Stake
GIP
26
Granite Investment Partners
California
$7.2M +$6.81M +211,040 New
BJCM
27
Blue Jay Capital Management
California
$7.16M -$4.52M -140,000 -40%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$6.82M +$1.65M +51,272 +35%
FCMI
29
Foresite Capital Management II
California
$6.32M +$5.98M +185,294 New
CM
30
Castleark Management
Illinois
$6.13M +$5.79M +179,616 New
FCMI
31
Foresite Capital Management III
California
$6.01M +$5.69M +176,211 New
TA
32
Teachers Advisors
New York
$5.94M -$2.9M -89,845 -34%
CAM
33
Cormorant Asset Management
Massachusetts
$5.8M -$67.2K -2,083 -1%
GC
34
Guggenheim Capital
Illinois
$5.73M +$5.42M +168,106 New
TCM
35
Tekla Capital Management
Massachusetts
$5.63M
SEI Investments
36
SEI Investments
Pennsylvania
$5.57M +$568K +17,600 +12%
MIM
37
Monashee Investment Management
Massachusetts
$5.27M -$1.02M -31,502 Closed
Goldman Sachs
38
Goldman Sachs
New York
$5M -$1.03M -32,023 -18%
Bank of America
39
Bank of America
North Carolina
$4.99M +$452K +14,009 +11%
SC
40
Samlyn Capital
New York
$4.98M +$613K +19,000 +15%
IHM
41
Iguana Healthcare Management
New York
$4.78M -$323K -10,000 -7%
Deutsche Bank
42
Deutsche Bank
Germany
$4.25M +$381K +11,809 +10%
PA
43
Perceptive Advisors
New York
$3.94M -$6.78M -210,000 -64%
Charles Schwab
44
Charles Schwab
California
$3.86M +$189K +5,850 +5%
TCIM
45
TIAA CREF Investment Management
New York
$3.79M +$506K +15,678 +16%
Allianz Asset Management
46
Allianz Asset Management
Germany
$3.77M +$192K +5,941 +6%
NIP
47
Nicholas Investment Partners
California
$3.63M -$888K -27,525 -21%
IBT
48
International Biotechnology Trust
United Kingdom
$3.58M +$1.94M +60,000 +133%
D.E. Shaw & Co
49
D.E. Shaw & Co
New York
$3.49M -$79.3K -2,458 -2%
PC
50
Polar Capital
United Kingdom
$3.41M +$3.23M +100,000 New

DERM Hedge Fund Activity: Q1 2017 in Review

134 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Dermira, Inc. (DERM) for Q1 2017, worth a combined $1.19B — up 33% from $890M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new DERM positions and 17 closed out — a net gain of 21 holders — while 50 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $107M. The largest seller was Fidelity Investments, cutting an estimated $48.2M.

  • 134 institutional investors held Dermira, Inc. (DERM) as of Q1 2017, up from 118 in Q4 2016.
  • Funds reported $1.19B of Dermira, Inc. stock for Q1 2017, up 33% quarter-over-quarter.
  • 38 funds opened new Dermira, Inc. positions in Q1 2017 and 17 closed out, a net change of +21 holders.
  • The largest Dermira, Inc. buyer in Q1 2017 was BlackRock, an estimated $107M added.
  • The largest Dermira, Inc. seller in Q1 2017 was Fidelity Investments, an estimated $48.2M sold.

Based on aggregated 13F filings for Q1 2017.